Artificial Intelligence Enhances NSCLC Care by Predicting Treatment Outcomes, Validating Neoadjuvant Therapies, and Improving Precision.
作者信息
Ishikawa Shumpei
机构信息
Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Division of Pathology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Chiba, Japan.
出版信息
J Thorac Oncol. 2024 May;19(5):666-667. doi: 10.1016/j.jtho.2024.02.003.
PMID:38719421
Abstract
摘要
Zotero 插件